New device may reduce repeat breast cancer surgeries

September 12, 2012 by Kathleen Doheny, Healthday Reporter
New device may reduce repeat  breast cancer surgeries
Tool could help surgeons determine if all cancerous tissue is excised in lumpectomy, study says.

(HealthDay)—A new device meant to help surgeons determine in the operating room if they have removed all cancerous breast cancer tissue may help reduce repeat surgeries after lumpectomy without compromising cosmetic effects, according to a new study.

The device, called MarginProbe, emits an electric field and senses a return signal from the tissue examined. provides a different electromagnetic signature than normal tissue, the researchers explained.

"This can potentially decrease having to go back to the operating room and with no real effect on your [cosmetic] outcome," said study leader Dr. Susan Boolbol, chief of at Beth Israel Medical Center, in New York City.

The study of nearly 500 patients undergoing breast-conserving surgery found little difference in the volume of tissue removed when the device was used compared to traditional detection methods.

"The reality is, most of the time we leave the and we don't know if we have a clear margin [with all cancer removed] or not," Boolbol said. Doctors wait for the pathology report to find that out, which can take a week or two. With the new device, the wait time is about five minutes.

"Everything still goes through pathology," Boolbol said. But the MarginProbe is another tool that might help reduce the odds of needing a subsequent surgery, she said.

Boolbol is scheduled to present the findings Thursday at the 's symposium in San Francisco.

In June, the radiation-free device won the blessing of a U.S. advisory panel. The FDA usually follows the advisory panel's recommendations, so device approval is anticipated.

For the study, Boolbol and her colleagues randomly assigned 495 to receive the MarginProbe after or not receive it. Of those, 161 had early cancer known as in situ. The others had invasive cancers.

Where the device detected cancer cells near the edge or surface of the sample examined, surgeons removed additional tissue in the same procedure.

Typically, about 40 percent of lumpectomy patients need another surgery because of the difficulty distinguishing between healthy and cancerous cells in tissue around the tumor.

"We looked at whether we could lower the [repeat surgery] rate by using this device," Boolbol said. The patients were followed for two months to see if they needed a repeat surgery. For those with ductal carcinoma in situ, 13 percent of the probe group needed a repeat surgery, compared to 37 percent of the control group.

Among women with invasive breast cancer, 17 percent in the device group and 33 percent in the comparison group required more surgery.

Looking at the volume of tissue excised, the researchers said not much more tissue was removed when the device was used compared to removed in the initial and subsequent surgeries among the control-group patients, Boolbol said.

Dr. Laura Kruper, director of the Cooper Finkel Women's Health Center and co-director of the breast cancer program at City of Hope Comprehensive Cancer Center in Duarte, Calif., said the device looks promising. However, she thinks more research is needed.

"I would like to see it [used] in a larger population," she said. If the results are repeated in larger studies, it could be a welcome addition to doctors' techniques, she said.

The expected cost of the MarginProbe in the United States, if approved, is not yet known, said Michael Graffeo, a spokesman for its maker, Dune Medical Devices. In Europe, where the device is available, each probe (one per patient) sells for about 600 euros or $760, he said. This is much less than the cost of re-operation, he noted.

The is also being studied for use with prostate cancer, the company said.

Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

Explore further: Fewer women need repeat breast cancer surgeries with new service at University of Michigan

More information: To learn more about breast cancer surgery, visit the American Cancer Society.

Related Stories

Fewer women need repeat breast cancer surgeries with new service at University of Michigan

February 28, 2012
Nearly one in three women who have breast cancer surgery will need to return to the operating room for additional surgery after the tumor is evaluated by a pathologist.

Researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers

October 27, 2011
A new study suggests some women needing a lumpectomy or mastectomy to treat their breast cancer have another potential option that is safe and effective, say researchers at Georgetown. They say the procedure known as a nipple ...

Ultrasound-guided surgery is best way to remove breast tumours

March 23, 2012
The use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as ...

Recommended for you

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.